A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration
Clinical trial NCT00056836 · COMPLETED
Trial details
- NCT number
- NCT00056836
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.